Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy

Melacini, P.; Moron, B. J.; Bobbo, F.; Basso, C.; Tokajuk, B.; Zucchetto, M.; Thiene, G.; Iliceto, S.
June 2007
Heart;Jun2007, Vol. 93 Issue 6, p708
Academic Journal
Objective: To determine the efficacy of pharmacological treatment in the prevention of sudden cardiac death in hypertrophic cardiomyopathy (HCM). Design: Clinical outcome was assessed retrospectively in 293 patients with HCM, including 173 who were taking cardioactive medications. Setting: Department of Cardiology, University of Padua, Padua, Italy; a tertiary HCM Centre. Interventions: Medical treatment with 3 blockers, verapamil, sotalol and amiodarone. Main outcome measure: HCM-related sudden cardiac death. Results: 17 of 173 (10%) patients died suddenly or had aborted cardiac arrest, while being treated continuously with drugs having antiarrhythmic properties, over a period of 62 (56) months. Sudden death occurred in 20% of patients administered amiodarone (6/30), 9% each of patients taking verapamil (4/46) or 13 blockers (7/76), and 0% of those taking sotalol (0/21). Patients taking cardioactive drugs (n = 173) and those without pharmaceutical therapy (n = 120) did not differ with respect to sudden death mortality. Conclusion: Medical treatment is not absolutely protective against the risk of sudden death in HCM. The present data inferentially support the use of the implantable defibrillator as the primary treatment choice for prevention of sudden death in high-risk patients with HCM.


Related Articles

  • Defibrillators found to benefit more patients. Parish, Linn // Journal of Business (10756124);6/19/2003, Vol. 18 Issue 13, pB3 

    Discusses a study which shows that implantable defibrillators are beginning to be used to help prevent cardiac arrest and sudden death in a broader range of heart disease sufferers. Projected increase of implantable defibrillator devices in preventive use; Arrhythmias that defibrillators...

  • Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy. Femenía, Francisco; Arce, Maurico; Grieken, Jorge; Trucco, Emilce; Mont, Luis; Abello, Mauricio; Merino, José; Rivero-Ayerza, Máximo; Gorenek, Bulent; Rodriguez, Carlos; Hopman, Wilma; Baranchuk, Adrian // Journal of Interventional Cardiac Electrophysiology;Dec2013, Vol. 38 Issue 3, p159 

    Objectives: This study aims to determine whether fragmented QRS (fQRS) in the surface electrocardiogram (ECG) at implantable cardioverter defibrillator (ICD) implant can predict arrhythmic events using appropriate therapy delivered by the ICD as a surrogate. Background: Hypertrophic obstructive...

  • Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. Maron, Barry J.; Spirito, Paolo; Win-Kuang Shen; Haas, Tammy S.; Formisano, Francesco; Link, Mark S.; Epstein, Andrew E.; Almquist, Adrian K.; Daubert, James P.; Lawrenz, Thorsten; Boriani, Giuseppe; Estes III, N. A. Mark; Favale, Stefano; Piccininno, Marco; Winters, Stephen L.; Santini, Massimo; Betocchi, Sandro; Arribas, Fernando; Sherrid, Mark V.; Buja, Gianfranco // JAMA: Journal of the American Medical Association;7/25/2007, Vol. 298 Issue 4, p405 

    This article presents the results of a study on implantable cardioverter-defibrillators (ICDs) and the prevention of sudden cardiac death in hypertrophic cardiomyopathy (HCM). The objective of the study was to look at the relationship between clinical risk profiles and the incidence and efficacy...

  • Effective and efficient use of implantable defibrillators: Sometimes it's over when it's over. Dorian, Paul // CMAJ: Canadian Medical Association Journal;3/17/2009, Vol. 180 Issue 6, p599 

    In this article the author discusses the issue whether implantable defibrillators are effective in preventing cardiac death among patients with heart failure. He presents the result of the study conducted by Soko Setoguchi and colleagues which focuses on the failure of implantable defibrillator...

  • Synchronous cardiac arrest in monozygotic twins with hypertrophic cardiomyopathy - Is sudden cardiac death genetically pre-programmed? Cheng Yee Goh; ul Haq, Muhammad Asrar; Mutha, Vivek; van Gaal, William J. // BMC Cardiovascular Disorders;Jul2015, Vol. 15 Issue 1, p1 

    Background: Hypertrophic cardiomyopathy (HCM) is a myocardial disorder characterised by left ventricular hypertrophy (LVH) in the absence of another cardiac or systemic disease capable of producing the magnitude of LVH evident. HCM causes variable symptoms and is one of the leading causes of...

  • Surviving hypertrophic cardiomyopathy: counting the cost of implantable cardioverter defibrillator therapy to prevent sudden death. Brady, Peter A. // Heart;Jan2012, Vol. 98 Issue 2, p97 

    This article discusses the use of implantable cardioverter defibrillator (ICD) therapy to prevent sudden death in persons with hypertrophic cardiomyopathy (HCM) due to a ventricular arrhythmia. It examines the reliability and effectiveness of ICD therapy. It also identifies the hurdles in the...

  • Perceptions of an Implantable Cardioverter-Defibrillator: A Qualitative Study of Families with a History of Sudden, Life-Threatening Cardiac Events, and Recommendations to Improve Care. Linder, Jarrett; Hidayatallah, Nadia; Stolerman, Marina; McDonald, Thomas V.; Marion, Robert; Walsh, Christine; Dolan, Siobhan M. // Einstein Journal of Biology & Medicine;2013, Vol. 29 Issue 1/2, p3 

    Objective: To identify major concerns associated with implantable cardioverter-defibrillators (ICDs) and to provide recommendations to adult and pediatric physicians involved in the care of patients with ICDs. Background: Cardiac ion channelopathies are a wellrecognized cause of sudden cardiac...

  • Prevention of sudden cardiac death in hypertrophic cardiomyopathy. O'Mahony, Constantinos; Elliott, Perry M. // Heart;Feb2014, Vol. 100 Issue 3, p254 

    The article focuses on the prevention of sudden cardiac death (SCD) in hypertrophic cardiomyopathy. Topics discussed include identifying patients who are at high risk to justify prophylactic medical intervention, preventing patients from participating in competitive sports and intense physical...

  • Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failure. Setoguchi, Soko; Nohria, Anju; Rassen, Jeremy A.; Stevenson, Lynne Warner; Schneeweiss, Sebastian // CMAJ: Canadian Medical Association Journal;3/17/2009, Vol. 180 Issue 6, p611 

    Background: Implantable defibrillators are recommended for the prevention of sudden cardiac death in patients with heart failure. However, criteria to identify those who would benefit most from this therapy are lacking. We assessed the maximum potential benefit of preventing sudden death in...


Read the Article


Sign out of this library

Other Topics